Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 19/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27204004 | 1.00 | STING1 (0.68) | STING1CYP3A4ENPP1 | |
| SCHEMBL28639271 | 0.91 | STING1 (0.62) | STING1CYP3A4ENPP1 | |
| SCHEMBL28639272 | 0.91 | STING1 (0.62) | STING1CYP3A4ENPP1 | |
| SCHEMBL27204069 | 0.90 | STING1 (0.64) | STING1CYP3A4ENPP1 | |
| SCHEMBL27204000 | 0.90 | STING1 (0.64) | STING1CYP3A4ENPP1 | |
| SCHEMBL27207233 | 0.88 | STING1 (0.66) | STING1CYP3A4 | |
| SCHEMBL21630050 | 0.88 | STING1 (0.66) | STING1CYP3A4 | |
| SCHEMBL21616437 | 0.88 | STING1 (0.84) | STING1CYP3A4 | |
| SCHEMBL27204051 | 0.88 | STING1 (0.84) | STING1CYP3A4 | |
| SCHEMBL22121447 | 0.87 | STING1 (0.66) | STING1CYP3A4ENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240132493-A1 | IMIDAZOPYRIDINE DERIVATIVES AS STING AGONISTS | FULGENT GENETICS INC (US) | 2024-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240132493-A1 | IMIDAZOPYRIDINE DERIVATIVES AS STING AGONISTS | STING1, IRF3, MAVS | STING1 1/4885CYP3A4 3589/4885ENPP1 596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.